EUVIMEDEUVIMED entdecken
Open Access

Human Epididymis Protein 4 Predicted Concurrent Intermediate-high-risk Endometrial Cancer and Eligibility of Fertility-sparing Treatment for Patients Diagnosed with Endometrial Atypical Hyperplasia Before Surgery

Yaochen Lou, Weirong Ma, Feng Jiang, Jun Guan

International Journal of Medical Sciences · 2025

DOI: 10.7150/ijms.115170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Yaochen Lou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Obstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of…. Hauptthemen laut MEDLINE: WAP Four-Disulfide Core Domain Protein 2, Endometrial Neoplasms, Fertility Preservation, Endometrial Hyperplasia. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

WAP Four-Disulfide Core Domain Protein 2Endometrial NeoplasmsFertility PreservationEndometrial HyperplasiaHumansFemaleRetrospective StudiesMiddle AgedAdultHysterectomyNomogramsROC CurveBiomarkers, TumorRisk Factors

Stichwörter der Autor:innen

endometrial atypical hyperplasiaendometrial cancerfertility-sparing treatmenthuman epididymis protein 4intermediate-high-risk

Substanzen

WAP Four-Disulfide Core Domain Protein 2WFDC2 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Gynecology, Obstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, 200433, Shanghai, Chi…
  • Department of Gynecology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, 210029, Nanjing, China.
  • Department of Neonatology, Obstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, 200433, Shanghai, Ch…

Zitieren

APA

Lou, Y., Ma, W., Jiang, F., & Guan, J. (2025). Human Epididymis Protein 4 Predicted Concurrent Intermediate-high-risk Endometrial Cancer and Eligibility of Fertility-sparing Treatment for Patients Diagnosed with Endometrial Atypical Hyperplasia Before Surgery. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.115170

Vancouver

Lou Y, Ma W, Jiang F, Guan J. Human Epididymis Protein 4 Predicted Concurrent Intermediate-high-risk Endometrial Cancer and Eligibility of Fertility-sparing Treatment for Patients Diagnosed with Endometrial Atypical Hyperplasia Before Surgery. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.115170

BibTeX
@article{Lou2025,
  author = {Lou, Yaochen and Ma, Weirong and Jiang, Feng and Guan, Jun},
  title = {Human Epididymis Protein 4 Predicted Concurrent Intermediate-high-risk Endometrial Cancer and Eligibility of Fertility-sparing Treatment for Patients Diagnosed with Endometrial Atypical Hyperplasia Before Surgery},
  journal = {International Journal of Medical Sciences},
  year = {2025},
  doi = {10.7150/ijms.115170}
}
Kostenlos starten →